openPR Logo
Press release

Sacral Neuromodulation Market Size, Revenue Analysis, Opportunities, Trends, Product Launch 2028

09-16-2022 11:55 AM CET | Health & Medicine

Press release from: Reports and Data

/ PR Agency: Reports and Data
Sacral Neuromodulation Market

Sacral Neuromodulation Market

Increasing elderly population, rise in the neurological diseases as well as failure of conventional treatments (exercise, changes in lifestyle, diet) to cure SNM expiries are key factors contributing to high CAGR of Sacral Neuromodulation during forecast period.

According to the current analysis of Reports and Data, the global Sacral neuromodulation market was valued at USD 2,432.9 Million in 2020 and is expected to reach USD 3,498.2 Million by year 2028, at a CAGR of 4.94 %. The study covers in-depth analysis of Sacral Neuromodulation and the treatments to cure it. Overactive bladder symptoms of urgency, frequency and incontinency is at present affecting a significant amount of population, especially when age increases. Sacral Neuromodulation (also known as sacral nerve stimulation) has been one of the popular and effective treatment options to cure overactive bladder and bowel problems for more than last 2 decades. The main purpose of the Sacral Neuro modulation is to improve the coordination between bladder/bowel and our brain. One of the proven treatments include sacral neuromodulation via the interstim system. The procedure is divided into two main stages which include basic evaluation and advanced evaluation. In both the evaluations a portable, external stimulator which generates stimulations is delivered through a lead.

Number of companies are engaged in launching new devices for SNM with minimal pain and side effects. For instance, launch of smaller implantable neurostimulator Interstim II manufactured by Medtronic has helped to improve patient 's comfort and has also made the procedure of the physicians easier and shorter. The patient has to wear the stimulator throughout the two evaluations. The basic evaluation includes simple, in-office procedure whereas the advanced evaluation is performed in hospitals, clinics, surgical centers. The global market is propelled by number of factors such as increasing geriatric, rise in the neurological diseases and failure of conventional treatments (exercise, changes in lifestyle, diet) to cure SNM. However adverse effects and complications in some of the SNM treatments are the major hindrances for market growth in 2019-2028.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC])@ https://www.reportsanddata.com/sample-enquiry-form/1487

The report provides comprehensive assessment of the market covering key elements such as revenue estimations, cost analysis, import/export, production and consumption trends, CAGR, gross margin, and supply & demand patterns. It also sheds light on recent technological developments, product advancements, and research and development activities in the region.

The report examines the key players operating in the market along with their market position, market share, revenue, gross margin, and business strategies. SWOT analysis and Porter's Five Forces Analysis are used to examine and assess the market and its players. It also covers recent mergers and acquisitions, joint ventures, collaborations, agreements, partnerships, and product launches and brand promotions.

Key companies profiled in the report include:

Cyberonics, St Jude Medicals, Boston Scientific, Medtronic.

Market Segmentation by Types:

Product (Revenue, USD Million; 2020-2028)

Implantable SNM devices
External SNM devices
Application (Revenue, USD Million; 2020-2028)

Urinary incontinence
Urge incontinence
Order this Report @ https://www.reportsanddata.com/report-pricing/1487

Regional analysis covers in-depth analysis of analysis of the revenue, market share, and growth rate of the global Sacral Neuromodulation market in each region for the forecast period of 2021-2028. The report covers production and consumption rate, current and emerging trends, import/export, supply and demand, and presence of key players in each region.

North America
U.S.
Canada
Mexico
Europe
Germany
U.K.
Italy
France
BENELUX
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
Middle East & Africa
Saudi Arabia
U.A.E.
South Africa
Rest of MEA
Further key findings from the report suggest

North America is the largest revenue generating region in the global Sacral neuromodulation market. It holds 35.5% of the total market share owing to the technological advancements and rising awareness about SNM. Followed by that, Europe accounts for 31.2% of the total market share.
Implantable SNM devices in comparison to external SNM devices is a more popular option on a global level. It holds 62.5% of the total market share whereas External SNM device holds 33.3% of the total market share.
Medtronic is the dominating player in manufacturing SNM instruments, devices in the global market. In 2015, Medtronic had net sales worth USD 3.8 billion in neuromodulation. Gastrointestinal and urological devices were the prime factors for the rapid growth of Medtronic.
Axonics Modulation Technologies acquired investments in SNM worth 38.5 million to extensively study about OAB implants in North America and Europe and is expected to surpass medical device giant Medtronic's popular and successful Interstim system in the coming future. The Axonics SNM system is compatible, given few precautions, with 1.5 Tesla and 3 Tesla MRI scanners. It is the only SNM system clearing in Europe with such labelling. Axonics 's SNM device is rechargeable and also has a guaranteed lifetime up to 15 years (3 times longer than Medtronic's Interstim). It is also 60% smaller than Interstim device.
Welkin Health, a privately-held patient relationship management software company has recently announced that it will be collaborating with Axonics Modulation Technologies in finding new solutions for SNM.
With only a handful of players in the market, there are tremendous opportunities for companies like Axonics to enter in the market.
Revenue from the sale of SNM devices is estimated to be rise around USD 600 million annually with nearly 30,000 devices implanted in patients in 2014 alone.
Revenue for this market is estimates to grow to over USD1 billion by the end of 2019.
According to a US-based study, overactive bladder (OAB) symptoms are prevalent in 17% males and 17.9% in female population in US.
In case of Europe, 16% men and 17.8% women above 40 years of age were estimated to have OAB symptoms in the coming years.
Associated side effects related to SNM treatments and lack of awareness about Sacral neuromodulation is likely to hinder the market growth during the forecast period.
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/1487

Thank you for reading our report. For further inquiry, please connect with us and our team will make sure the report is customized according to your requirements.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Sacral Neuromodulation Market Size, Revenue Analysis, Opportunities, Trends, Product Launch 2028 here

News-ID: 2737560 • Views: 186

More Releases from Reports and Data

Cervical Dysplasia Market-Upcoming Trends and Emerging Growth Factors to 2028
The Global Cervical Dysplasia Market report published by Reports and Data is a concise summary on the Cervical Dysplasia industry and offers deep insights into the industry's core structure and mechanism. The report digs into the key segments and sub-segments of the industry and offers a thorough study of the industry's leading regional markets, competitive scenario, product and application segments, technology landscape, sales & distribution networks, and key industry statistics.
Gynecological Devices Market- Growth Drivers Analysis and Business Trends Insigh …
The global Gynecological Devices market report published by Reports and Data assesses the Gynecological Devices market with regards to market size, market share, revenue growth, key segments, and regional bifurcation. The global Gynecological Devices market is highly fragmented with numerous players operating on a global and regional level. The companies are engaged in mergers and acquisitions, joint ventures, and collaborations along with product advancements and R&D activities to cater to
Cholesterol Meter Market Growth Overview With Upcoming Opportunities Industry Tr …
The global Cholesterol Meter market report published by Reports and Data assesses the Cholesterol Meter market with regards to market size, market share, revenue growth, key segments, and regional bifurcation. The global Cholesterol Meter market is highly fragmented with numerous players operating on a global and regional level. The companies are engaged in mergers and acquisitions, joint ventures, and collaborations along with product advancements and R&D activities to cater to
Antidiuretic Drugs Market Future Growth Scenario, Recent Trends, Industry Player …
The Global Antidiuretic Drugs Market report published by Reports and Data is a concise summary on the Antidiuretic Drugs industry and offers deep insights into the industry's core structure and mechanism. The report digs into the key segments and sub-segments of the industry and offers a thorough study of the industry's leading regional markets, competitive scenario, product and application segments, technology landscape, sales & distribution networks, and key industry statistics.

All 5 Releases


More Releases for SNM

Sacral Neuromodulation Market Size To Reach USD 3,498.2 Million By 2028 Says Rep …
The research report on the Global Sacral Neuromodulation Market added by Reports and Data presents a comprehensive assessment of the market including current and future trends, current factors driving and restraining market growth, and expert validated market data. The report also discusses the market segmentation by types, applications, and key regions. Key manufacturers and companies along with their company overview, business expansion plans, SWOT analysis and Porter’s Five Forces analysis
Global Overactive Bladder (OAB) Treatment Market Analysis By Medication, By Ther …
This report helps to analyze competitive developments such as Joint Ventures, Strategic Alliances, Mergers and Acquisitions, New Product Developments, And Research and Developments in the "Overactive Bladder (OAB) Treatment Market". Global Overactive Bladder Treatment Market was valued at USD 4978.09 Million in the year 2018. New emerging technologies and drug development with expanding health expenditure and infrastructure, rising number of elderly people etc. is driving the Overactive Bladder Treatment market. Further,
Latest Trends In Sacral Neuromodulation Market To Grow at 4.94 % of CAGR by 2026 …
According to the current analysis of Reports and Data, the global Sacral neuromodulation market was valued at USD 2189.1 million in 2018 and is expected to reach USD 3153.4 million by year 2026, at a CAGR of 4.94 %. The study covers in-depth analysis of Sacral Neuromodulation and the treatments to cure it. Overactive bladder symptoms of urgency, frequency and incontinency is at present affecting a significant amount of population,
Potassium Nitrate Market 2018 Global Key Players: SNM, Yufeng, KEMAPCO, MC, Fuyu …
Reportsandinsights.com Presents “Global Potassium Nitrate Market Size, Status and Forecast” New Document to its Studies Database. The Report Contain 105 Pages with Detailed Analysis Description: Based on the Potassium Nitrate industrial chain, this report mainly elaborate the definition, types, applications and major players of Potassium Nitrate market in details. Deep analysis about market status (2012-2017), enterprise competition pattern, advantages and disadvantages of enterprise Products, industry development trends (2017-2022), regional industrial layout
Global Potassium Nitrate market 2017 - Tengda Industrial, MC, YNCC, Yufeng, SNM, …
Apex Market Reports, recently published a detailed market research study focused on the "Potassium Nitrate Market" across the global, regional and country level. The report provides 360° analysis of "Potassium Nitrate Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Potassium Nitrate industry, and estimates the future trend of Potassium Nitrate market
GMI Will Attend SNM Conference
June 1, 2011, Charlotte, NC - Global Medical Imaging is please to announce their attendance at this year’s Society for Nuclear Medicine (SNM) annual meeting in San Antonio, Texas. The SNM event is an opportunity for GMI to expand their knowledge on the latest molecular imaging and nuclear medicine, allowing them to continue providing premier full-service medical imaging solutions. GMI will have the opportunity to engage with the molecular imaging